Key Takeaways
- Northrop Grumman stock dropped approximately 2% following first-quarter results, even after surpassing EPS expectations with $6.14 versus the forecasted $6.03 and posting revenue of $9.88 billion, representing 4.4% annual growth
- Aeronautics division revenue surged 17%, fueled by the B-21 Raider bomber transitioning into low-rate initial production phase
- U.S. Air Force authorized a 25% increase in annual B-21 manufacturing capacity
- Total backlog reaches $96 billion, with $2.5 billion earmarked for B-21 production facility investments extending to 2029
- Analyst consensus rating is Moderate Buy, featuring an average price objective of $743.33, suggesting roughly 29% potential appreciation
Northrop Grumman (NOC) delivered first-quarter results on April 21 that exceeded Wall Street expectations, yet shares declined by approximately 2%. The counterintuitive market response warrants closer examination of the underlying details.
Northrop Grumman Corporation, NOC
Adjusted earnings per share registered at $6.14, surpassing the analyst consensus of $6.03. Total revenue reached $9.88 billion, representing a 4.4% increase compared to the prior-year period and exceeding the $9.75 billion forecast. From a fundamental perspective, the company delivered across key metrics.
The subdued market reaction appears connected to a $200 million upward revision in 2026 capital spending projections and a $71 million adverse adjustment within the Space division tied to the GEM 63XL program. While neither development signals a major problem, market participants reacted cautiously.
The Aeronautics segment emerged as the quarter’s performance leader. Revenue increased 17%, propelled by the B-21 Raider stealth bomber entering low-rate initial production. Segment margins improved to 9.3%, partially attributed to the absence of loss charges that impacted results in early 2025.
Additionally, the Air Force approved a 25% expansion in annual B-21 production capacity. This represents tangible evidence of sustained demand rather than speculative forecasting.
Defense Systems recorded 5% revenue growth, with the Sentinel intercontinental ballistic missile program continuing its development trajectory. Mission Systems revenue remained essentially unchanged, though operating income jumped 20%, supported by favorable contract modifications.
B-21 Production Expansion Enhances Revenue Predictability
Company leadership announced plans to allocate $2.5 billion in internal capital toward B-21 manufacturing facilities through 2029. Over the past two years, Northrop has inaugurated more than 20 new facilities, demonstrating its commitment to scaling production capabilities.
The contract backlog stands at $96 billion. This figure represents approximately two to three years of forward revenue already secured. Full-year 2026 EPS guidance was established at $27.40–$27.90, which leadership maintained essentially unchanged following the quarterly report.
Shares currently trade at approximately 21x the 2026 consensus EPS projection of $27.93. The 52-week trading range spans from $453.01 to $774.00, with NOC opening Monday at $575.57 — positioned below both its 50-day moving average of $699.43 and 200-day average of $638.36.
Wall Street Maintains Constructive Outlook
Vanguard Group expanded its NOC holdings by 1.5% during the fourth quarter, elevating its ownership stake to approximately 9.63% of outstanding shares.
Regarding analyst coverage, Royal Bank of Canada elevated its price target to $750 while maintaining an Outperform rating. Deutsche Bank holds a Buy recommendation with a $765 objective. UBS reduced its target from $806 to $745 while preserving a Buy rating. Citigroup similarly lowered its target from $807 to $742, sustaining a Buy stance. Jefferies shifted to a Hold position.
Wall Street consensus stands at Moderate Buy, derived from 10 Buy ratings and five Hold ratings. Zero analysts currently assign NOC a Sell recommendation. The mean price target of $743.33 indicates approximately 29% upside potential from present trading levels.
The company also announced a quarterly dividend of $2.31 per share, distributed March 11, translating to an annualized payout of $9.24 and a yield of 1.6%.
The latest insider transaction involved CAO Michael Hardesty selling 147 shares at $732.98 per share on February 19.
